Amida Capital Management II’s Syneron Medical Ltd ELOS Stock Holding History

Amida Capital Management II’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$34K	Buy	+3,300	New	+$35.7K	0.04%	83

Other funds holding ELOS

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Amida Capital Management II's ELOS Position: Q2 2014 in Review

Amida Capital Management II opened a new position in Syneron Medical Ltd (ELOS) in Q2 2014: 3,300 shares worth $34K. The stake represents 0.04% of the portfolio and ranks #83 among its holdings.

61 funds tracked by Wall St. Rank hold ELOS as of Q2 2014.

Amida Capital Management II held 3,300 shares of Syneron Medical Ltd worth $34K as of Q2 2014.
Syneron Medical Ltd was a new Amida Capital Management II position in Q2 2014.
Syneron Medical Ltd made up 0.04% of Amida Capital Management II's portfolio in Q2 2014, its #83 holding.
61 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2014.

Based on Amida Capital Management II's 13F filing for Q2 2014, filed 11 Aug 2014.